Dattoli Cancer Foundation logo  

About Us

Cancer of the prostate is the second leading cause of male cancer death in the United States. Approximately 220,000 new cases will be diagnosed this year and nearly 30,000 men will die from the disease. Despite the gravity of a prostate cancer diagnosis, there is a surprising amount of good news to report about this disease today.

First, although statistics show prostate cancer is on the rise, we know much of this is due to a dramatic increase in early detection. Screening procedures are more common and heightened public awareness has helped more men ask their doctors to be tested. Second, extensive research in this field of medicine has lead to great advances in treatment and care of prostate cancer patients. And third, these new treatment options, the most remarkable of which is called brachytherapy have profoundly improved the standards for quality of life.

The Dattoli Cancer Foundation was established in 2000 to help increase awareness about the importance of PSA screening; to offer current, accurate information about leading edge treatment for prostate cancer; and to foster research into even better treatment options.

The Foundation is named for Dr. Michael Dattoli, a living pioneer in the field of brachytherapy for the treatment of prostate cancer. Dr. Dattoli and his partner Dr. Richard Sorace are credited with many advances in refining and targeting external beam radiation and precise intra- and extracapsular radioactive seed placement. At the time of the creation of this Foundation, the Dattoli Team has treated over 7,000 men from all corners of the world. Dr. Dattoli is a frequent lecturer and author of a number of textbooks and journal articles.

The Dattoli Cancer Center and Brachytherapy Research Institute in Sarasota, Florida, is unparalleled anywhere in the world for its combination of state-of-the-art technology and clinical expertise. For more information about Drs. Dattoli and Sorace as well as the Dattoli Cancer Center, visit www.dattoli.com.

Staff members of the Foundation include Ginya Carnahan, CPRC, Director of Development, and Amber Kawlewski, Patient Programs Director. Together this team strives to offer support, hope and education to prostate cancer patients and their families.